Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Minority Interest: 2022-2024

Historic Minority Interest for P3 Health Partners (PIII) over the last 3 years, with FY2024 value amounting to $73.6 million.

  • P3 Health Partners' Minority Interest fell 7376.93% to $37.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.6 million, marking a year-over-year decrease of 7376.93%. This contributed to the annual value of $73.6 million for FY2024, which is 7475.65% down from last year.
  • According to the latest figures from FY2024, P3 Health Partners' Minority Interest is $73.6 million, which was down 7475.65% from $291.5 million recorded in FY2023.
  • In the past 5 years, P3 Health Partners' Minority Interest ranged from a high of $516.8 million in FY2022 and a low of $73.6 million during FY2024
  • For the 3-year period, P3 Health Partners' Minority Interest averaged around $294.0 million, with its median value being $291.5 million (2023).
  • In the last 5 years, P3 Health Partners' Minority Interest crashed by 4358.96% in 2023 and then tumbled by 7475.65% in 2024.
  • P3 Health Partners' Minority Interest (Annual) stood at $516.8 million in 2022, then tumbled by 43.59% to $291.5 million in 2023, then crashed by 74.76% to $73.6 million in 2024.
  • Its last three reported values are $73.6 million in FY2024, $291.5 million for FY2023, and $516.8 million during FY2022.